Corporate

Top 300 Lodi: IBSA Italy is the only pharmaceutical company among the top 10 local businesses

The Top 300 Dossier, which showcases the excellence of Lodi’s entrepreneurial scene, marks a significant evolution compared to the previous Top 200 edition. By expanding the scope to include an additional 100 companies, it offers a broader and more in-depth overview of the growth, peculiarities and successes of local businesses. 

For the seventh consecutive year, IBSA Italy has been confirmed as one of the top ten companies in the sector survey, standing out as the only pharmaceutical company in the ranking capable of contributing to local economic growth, attracting investments and fostering the social and occupational progress of the area. Promoted by Assolombarda in collaboration with PwC, Banco BPM and Il Cittadino di Lodi, the Top 300 project analyses the economic and financial results of companies and the local entrepreneurial successes, providing a detailed picture of the performance in the area and the potential for future development.  

This significant result reflects a well-established strategy based on innovation, focus on sustainability and the centrality of People, values that guide every initiative of the company. A tangible example of this vision is the antares headquarters, recently renovated with an investment of € 17 million. The complete overhaul of the interior and exterior spaces resulted in a cutting-edge facility that combines energy efficiency with environmental sustainability, marking a step forward in the company’s growth. 

As emphasised by Giuseppe Celiberti, General Manager of IBSA Italy: “The streamlined and flexible organisational model, the collaboration between the various teams and the ability to adapt are the foundation of IBSA Italy’s success. In 2024, we achieved significant milestones, expanding our facilities and strengthening our production lines, while keeping innovation and the value of people at the core of our effort”

Thanks to this strategic vision, IBSA Italy continues to serve as a benchmark not only in the pharmaceutical sector, but also in the economic and social development of the Lodi area – a concrete example of how innovation and territorial commitment can coexist, making IBSA also a model for other local businesses.

topten lodi300